Skip to content
Alcyone Tx
Contact
About
Our Company
Our Team
Board of Directors
Strategic Collaborators
Science & Technology
Platforms
CLN3 Gene Therapy
Efralex
miREX
Falcon™
ThecaFlex DR
x
™ System
Publications
Pipeline & Programs
Pipeline
EPH-101
XGR-101
Investors & Media
Investors
Press Releases
Careers
Contact
Investors & Media
Press
Releases
June 27, 2023
Alcyone Therapeutics Receives FDA IDE Approval to Initiate Clinical Study of the ThecaFlex DRx™ System for Administration of SPINRAZA® (nusinersen)
January 4, 2023
Biogen and Alcyone Therapeutics Announce License and Collaboration Agreement to Evaluate a Novel Device to Improve Patient Experience and Access to Neurological ASO Therapies